| [1] Wang C C. Wang Chungcheng’s neurosurgery [M]. Wuhan: Hubei Science and Technology Publishing Company, 2005: 620-638.[2] Wakai S, Yamakawa K, Manaka S, et al. Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance[J]. Neurosurgery, 1982, 10(4): 437-444.[3] Wakai S, Fukushima T, Teramoto A, et al. Pituitary apoplexy: its incidence and clinical significance (author's transl)[J]. No to shinkei, 1981, 33(3): 561-568.[4] Findling J W, Tyrrell J B, Aron D C, et al. Silent pituitary apoplexy: subclinical infarction of an adrenocorticotropin-producing pituitary adenoma[J]. J Clin Endocrinol Metab, 1981, 52(1): 95-97.[5] Ostrov S G, Quencer R M, Hoffman J C, et al. Hemorrhage within pituitary adenomas: how often associated with pituitary apoplexy syndrome? [J]. AJR Am J Roentgenol, 1989, 153(1): 153-160.[6] Nawar R N, AbdelMannan D, Selman W R, et al. Pituitary tumor apoplexy: a review[J]. J Intensive Care Med, 2008, 23(2): 75-90.[7] Carmeliet P. Angiogenesis in health and disease[J]. Nat Med, 2003, 9 (6): 653-660.[8] Ferrara N. Vascular endothelial growth factor: basic science and clinical progress[J]. Endocr Rev, 2004, 25(4): 581-611.[9] Arita K, Kurisu K, Tominaga A, et al. Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma[J]. Hiroshima J Med Sci, 2004, 53(2): 23-27.[10] Fukui S, Nawashiro H, Otani N, et al. Vascular endothelial growth factor expression in pituitary adenomas[J]. Acta Neurochir(suppl), 2003, 86: 519-521.[11] Yarman S, Kurtulmus N, Canbolat A, et al. Expression of Ki-67, P 53 and vascular endothelial growth factor(VEGF) concomitantly in growth hormone-secreting pituitary adenomas; which one has a role in tumor behavior? [J]. Neuro Endocrinol Lett, 2010, 31(6): 823-828.[12] Niveiro M, Aranda F I, Peiro G, et al. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas[J]. Hum Pathol, 2005, 36(10): 1090-1095.[13] Onofri C, Theodoropoulou M, Losa M, et al. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours[J]. J Endocrinol, 2006, 191(1): 249-261.[14] Pizarro C B, Oliveira M C, Pereira-Lima J F, et al. Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker[J]. Neuropathology, 2009, 29(1): 40-44.[15] Gorczyca W, Hardy J. Microadenomas of the human pituitary and their vascularization[J]. Neurosurgery, 1988, 22(1Pt1): 1-6.[16] Turner H E, Harris A L, Melmed S, et al. Angiogenesis in endocrine tumors[J]. Endocr Rev, 2003, 24(5): 600-632.[17] Lee J S, Park Y S, Kwon J T, et al. Radiological apoplexy and its correlation with acute clinical presentation, angiogenesis and tumor microvascular density in pituitary adenomas[J]. J Korean Neurosurg Soc, 2011, 50(4): 281-287.[18] McCabe C J, Boelaert K, Tannahill L A, et al. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors[J]. J Clin Endocrinol Metab, 2002, 87(9):4238-4244.[19] Murad-Kejbou S, Eggenberger E. Pituitary apoplexy: evaluation, management, and prognosis[J]. Curr Opin Ophthalmol, 2009, 20(6): 456-461.[20] Cheng S Y, Nagane M, Huang H S, et al. Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189[J]. Proc Natl Acad Sci USA, 1997, 94(22): 12081-12087.[21] Jung S, Moon K S, Jung T Y, et al. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage[J]. J Neurooncol, 2006, 76(3): 257-263.[22] Kong Y G, Ren Z Y, Su C B, et al. Expressive level of vascular endothelial growth factor in peripheral blood in patients with pituitary adenomas[J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2004, 26(2): 164-167.[23] Jin Kim Y, Hyun Kim C, Hwan Cheong J, et al. Relationship between expression of vascular endothelial growth factor and intratumoral hemorrhage in human pituitary adenomas[J]. Tumori, 2011, 97(5): 639-646.[24] Cohen A B, Lessell S. Angiogenesis and pituitary tumors[J]. Semin Ophthamol, 2009, 24(3): 185-189.[25] Onofri C, Losa M, Uhl E, et al. Immunohistochemical analysis of VEGF-C/VEGFR-3 system and lymphatic vessel extent in normal and adenomatous human pituitary tissues[J]. Exp Clin Endocrinol Diabetes, 2008, 116(3): 152-157.[26] Cristina C, Perez-Millan M I, Luque G, et al. VEGF and CD31 association in pituitary adenomas[J]. Endocr Pathol, 2010, 21(3): 154-160.[27] Xiao Z, Liu Q, Mao F, et al. TNF-α-Induced VEGF and MMP-9 expression promotes hemorrhagic transformation in pituitary adenomas[J]. Int J Mol Sci, 2011, 12(6): 4165-4179. |
